Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?
Energy Fuels is up 36% in three months on strong uranium output, but a stretched valuation and 2025 loss forecast raise red flags.
In the most recent trading session, Energy Fuels (UUUU) closed at $5.59, indicating a -4.12% shift from the previous trading day.
Recently, Zacks.com users have been paying close attention to Energy Fuels (UUUU). This makes it worthwhile to examine what the stock has in store.
In the most recent trading session, Energy Fuels (UUUU) closed at $6.17, indicating a -1.44% shift from the previous trading day.
Initiate Energy Fuels (UUUU) at Strong Buy with $13 PT, citing unique U.S. uranium leverage, rare earth integration, and macro nuclear tailwinds. Pinyon Plain project offers structural cost advantage and margin dominance, redefining U.S. uranium supply curve with industry-leading grades and operational control. Rare earths pipeline is a key rerating catalyst, with North America's only operational monazite-derived supply chain and strategic expansion plans in place.
Zacks.com users have recently been watching Energy Fuels (UUUU) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Energy Fuels secures final approval to advance its Donald Project JV, unlocking a key near-term rare earth supply for U.S. processing.
Energy Fuels ramps U.S. uranium output while NexGen Energy readies a low-cost project. Let's asses which stock is better positioned for the nuclear boom.
The latest trading day saw Energy Fuels (UUUU) settling at $5.50, representing a +1.66% change from its previous close.
Energy Fuels shifts strategy from uranium, leaning on HMS assets like Toliara and Bahia.
Energy Fuels offers unique exposure to uranium and rare earths, but current sales and profits lag far behind its strategic promise. Despite a debt-free balance sheet and strong assets, revenue is low, losses are high, and commercial contracts for rare earths are still pending. The stock is highly speculative—best suited for risk-tolerant, long-term investors who believe in a US nuclear and rare earth renaissance.